Gamelin Erick sold ACRV
August 18, 2026 · Form 4 insider transaction
Gamelin Erick sold 400 shares of Acrivon Therapeutics, Inc. at $2.01 per share, a transaction worth $804.00. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$2.01
Total value
$804.00
InsiderGamelin Erick
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 18, 2026
Filing dateAugust 20, 2026
Shares owned after52,592
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.